from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0952/sucD

LFCtreatmentdescriptionclass of inhibitor

-1.231

Amikacinug/mL Amikacintranslation

-0.381

Cap5-10ug/mL Capreomycintranslation

-0.096

Rox10-50 ug/mL Roxithromycintranslation

0.412

SM2-5 ug/mL Streptomycintranslation

-1.065

Tet5-10 ug/mL Tetracyclinetranslation

-1.388

Rif0.2-5ug/mL Rifampicintranscription

-1.107

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.132

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.694

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.482

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.454

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.787

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.244

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.033

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.152

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.011

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.009

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.852

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.530

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.737

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.067

KCN5-20 ug/mL Potassium cyaniderespiration

0.212

NaN30.2-2 mM Sodium aziderespiration

0.307

Nigericin50 uM Nigericinrespiration

-1.182

TRC10-150 ug/mL Triclosanrespiration

0.454

TRZ10-25 ug/mL Thioridazinerespiration

-0.162

Valinomycin0.5-10 uM Valinomycinrespiration

-0.187

ZnSO42 mM ZnSO4respiration

0.367

menadione6-10 ug/mL Menadionerespiration

0.242

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.510

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.400

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.587

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.349

NRP_1Non-replicating persistence stage 1dosRassociated

0.252

Amp0.2mg/mL AmpicillincellWall

0.460

Cephalexin20-100 ug/mL CephalexincellWall

0.466

Cerulenin0.32-5 ug/mL CerulenincellWall

1.340

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.443

EMB10-20 ug/mL EthambutolcellWall

0.123

Eta12-40 ug/mL EthionamidecellWall

0.494

INH0.2-0.4 ug/mL IsoniazidcellWall

0.153

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.403

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.953

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.483

BZA0.12 mg/mL BenzamidearomaticAmides

-0.518

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.094

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.019

H2O24 mM hydrogen peroxideDNAdamaging

-0.505

Levo10 ug/mL LevofloxacinDNAdamaging

0.709

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.674

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.188

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.636

UVUV-irradiationDNAdamaging

-0.101

ARP41-4 ug/mL Antitubercular compound ARP4?

0.464

Antimycin12.5-50 ug/mL Antimycin A?

0.306

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.935

PA_110-50 ug/mL Antitubercular compound PA-1?

0.895

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.945

PA8240.2-2 ug/mL PA-824?

-0.688

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.108

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.044

Verapamil50 uM Verapamil?

0.746

mercaptoethanol2 mM 2-Mercaptoethanol?

0.522

methoxatin10-20 ug/mL Methoxatin?